Actively Recruiting
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2026-03-05
300
Participants Needed
1
Research Sites
571 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Systemic autoinflammatory diseases (SAIDs) are a set of rare clinically and genetically heterogeneous conditions. The project proposes to identify novel genes and specific signatures in subgroups of patients with SAIDs.
CONDITIONS
Official Title
Molecular Diagnosis of Systemic Autoinflammatory Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with clinical and biological aseptic inflammatory syndrome showing one or more of the following: spontaneously resolving fever; abdominal symptoms such as pain or diarrhea; locomotor symptoms including joint or muscle pain; thoracic symptoms like chest pain or pericarditis; skin involvement; sensory issues such as uveitis or deafness; or kidney problems such as amyloidosis.
You will not qualify if you...
- Adult under legal protection measures such as guardianship, curatorship, or safeguard of justice.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Trousseau Hospital
Paris, France, 75012
Actively Recruiting
Research Team
I
Irina GIURGEA
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here